Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX4 after Hepatic Resection for HCC with PVTT
NCT02452853Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- May 2015
- Primary completion
- May 2016
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of oxaliplatin in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02452853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452853.